Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.6.1 (
sulfatase
)
3,205
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Sodium 2-hydroxy-5-nitro-alpha-toluenesulfonate (
HNT
, compound II, Fig. 7) is a synthetic inhibitor of
arylsulfatase
(E.C. 3.1.6.1.). At 1 to 10 mM,
HNT
increased the clotting time of heparinized rabbit blood by 7-fold. In the 6-day chick embryo, mixtures of heparin and hydrocortisone applied to the chorioallantoic membrane, are known to inhibit specifically the growth of capillary blood vessels.
HNT
potentiated this antiangiogenic activity in a dose-dependent manner when the concentration of heparin was suboptimal. Potentiation of the antiangiogenic activity of steroids by
HNT
correlated inversely with the concentration of exogenous heparin. In the absence of exogenous heparin, hydrocortisone did not inhibit angiogenesis. Hydrocortisone and
HNT
, however, inhibited angiogenesis to the same extent as hydrocortisone and heparin. An
arylsulfatase
with a Km of 1.5 mM for nitrocatechol sulfate as substrate and a Ki of 10.0 microM for the inhibition of
HNT
, was identified in the chick embryo chorioallantoic membrane. Preincubation of heparin with a commercially available
arylsulfatase
caused a 50% reduction in antiangiogenic activity of heparin-steroid mixtures applied to the chorioallantoic membrane. This loss of activity was prevented completely by addition of
HNT
to the
arylsulfatase
-heparin incubation mixture. These results suggest that
HNT
(a) potentiates the anticoagulant function of heparin, (b) prevents the inactivation of antiangiogenic activity of heparin by an endogenous
arylsulfatase
in the chorioallantoic membrane and by a commercial
arylsulfatase
, and (c) in the presence of angiostatic steroids can inhibit angiogenesis in the chick embryo without the addition of exogenous heparin. On the basis of these data, we propose that this inhibitor of
arylsulfatase
acts to potentiate angiostatic steroids by suppressing the desulfation of tissue heparin.
...
PMID:Potentiation of angiostatic steroids by a synthetic inhibitor of arylsulfatase. 245 97